The risk of psychotic symptoms associated with recreational methamphetamine use

Drug and Alcohol Review

Volumn 29, Issue 4, 2010, Pages 358-363

  McKetin, Rebecca ^a   Hickey, Karina ^a,b   Devlin, Kristina ^b   Lawrence, Kerri ^b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b Manly Drug Education and Counselling Centre   (Australia)

Author keywords

Mental health; Methamphetamine; Psychosis; Recreational drug use; Stimulant

Indexed keywords

METHAMPHETAMINE; STREET DRUG;

ADOLESCENT; ADULT; ARTICLE; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; DRUG ABUSE; FEMALE; HUMAN; MALE; PSYCHOLOGICAL ASPECT; PSYCHOSIS; RISK FACTOR;

ADOLESCENT; ADULT; AMPHETAMINE-RELATED DISORDERS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; METHAMPHETAMINE; PSYCHOTIC DISORDERS; RISK FACTORS; STREET DRUGS; YOUNG ADULT;

EID: 77957913646     PISSN: 09595236     EISSN: 14653362     Source Type: Journal    
DOI: 10.1111/j.1465-3362.2009.00160.x     Document Type: Article

References (25)

1. United Nations Office on Drugs and Crime. World drug report. Vienna: United Nations Publications, 2007.
2. Curran C, Byrappa N, McBride A. Stimulant psychosis: systematic review. Br J Psychiatry 2004;185:196-204.
3. McKetin R, McLaren J, Lubman DI, Hides L. The prevalence of psychotic symptoms among methamphetamine users. Addiction 2006;101:1473-78.
4. Chen CK, Lin SK, Sham PC, et al. Pre-morbid characteristics and co-morbidity of methamphetamine users with and without psychosis. Psychol Med 2003;33:1407-14.
5. Farrell M, Boys A, Bebbington P, et al. Psychosis and drug dependence: results from a national survey of prisoners. Br J Psychiatry 2002;181:393-98.
6. Hall W, Hando J, Darke S, Ross J. Psychological morbidity and route of administration among amphetamine users in Sydney, Australia. Addiction 1996;91:81-7.
7. Matsumoto T, Kamijo A, Miyakawa T, et al. Methamphetamine in Japan: the consequences of methamphetamine abuse as a function of route of administration. Addiction 2002;97:809-17.
8. Australian Institute of Health and Welfare. 2007 National Drug Strategy Household Survey detailed findings. Drug statistics series no. 22. Cat. no. PHE 107. Canberra: Australian Institute of Health andWelfare, 2008:64.
9. Kinner SA, Degenhardt L. Crystal methamphetamine smoking among regular ecstasy users in Australia: increases in use and associations with harm. Drug Alcohol Rev 2008;27:292-300.
10. Degenhardt L, Topp L. 'Crystal meth' use among polydrug users in Sydney's dance party subculture: characteristics, use patterns and associated harms. Int J Drug Policy 2003;14:17-24.
11. McCambridge J, Mitcheson L, Winstock A, Hunt N. Fiveyear trends in patterns of drug use among people who use stimulants in dance contexts in the United Kingdom. Addiction 2005;100:1140-9.
12. Parks KA, Kennedy CL. Club drugs: reasons for and consequences of use. J Psychoactive Drugs 2004;36:295-302.
13. Riley SC, James C, Gregory D, Dingle H, Cadger M. Patterns of recreational drug use at dance events in Edinburgh, Scotland. Addiction 2001;96:1035-47.
14. Sheridan J, McMillan K, Wheeler A, Lovell C, Lee M, Ameratunga S. Methamphetamine and injury: a survey of individuals attending a 1-day music festival in New Zealand-piloting a new methodology. J Subst Use 2008; 13:49-56.
15. Hall W, Hando J. Route of administration and adverse effects of amphetamine use among young adults in Sydney, Australia. Drug Alcohol Rev 1994;13:277-84.
16. Bamford NS, Zhang H, Joyce JA, et al. Repeated exposure to methamphetamine causes long-lasting presynaptic corticostriatal depression that is renormalized with drug readministration. Neuron 2008;58:89-103.
17. Clemens KJ, Van Nieuwenhuyzen PS, Li KM, Cornish JL, Hunt GE, McGregor IS. MDMA ('ecstasy'), methamphetamine and their combination: long-term changes in social interaction and neurochemistry in the rat. Psychopharmacology 2004;173:318-25.
18. Perala J, Suvisaari J, Saarni SI, et al. Lifetime prevalence of psychotic and bipolar I disorders in a general population [see comment]. Arch Gen Psychiatry 2007;64:19-28.
19. Kendler KS, Gallagher TJ, Abelson JM, Kessler RC. Lifetime prevalence, demographic risk factors, and diagnostic validity of nonaffective psychosis as assessed in a US community sample. The National Comorbidity Survey. Arch Gen Psychiatry 1996;53:1022-31.
20. Scott J, Chant D, Andrews G, McGrath J. Psychotic-like experiences in the general community: the correlates of CIDI psychosis screen items in an Australian sample. Psychol Med 2006;36:231-8.
21. Jablensky A, McGrath J, Herrman H, et al. Psychotic disorders in urban areas: an overview of the study on low prevalence disorders. Aust N Z J Psychiatry 2000;34:221-36.
22. Weinberg NZ, Glantz MD. Child psychopathology risk factors for drug abuse: overview. J Clin Child Psychol 1999;28:290-97.
23. Teesson M, Degenhardt L, Hall W, Lynskey M, Patton G, Toumbourou J. Substance use and mental health in longitudinal perspective. In: Stockwell T, Loxsley W, Toumbourou J, eds. Evidence for prevention. NewYork: Wiley & Sons, 2005:43-51.
24. Schuckit MA.Comorbidity between substance use disorders and psychiatric conditions. Addiction 2006;101:76-88.
25. Sato M, Chen CC, Akiyama K, Otsuki S. Acute exacerbation of paranoid psychotic state after long-term abstinence in patients with previous methamphetamine psychosis. Biological Psychiatry 1983;18:429-40.